Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.03-$2.68 |
Market Cap | $1B |
Shares Short | 32M |
Financials
See moreRevenue (12 Mos) | $41.4M |
Revenue Growth (YoY) | -97.6% |
Gross Profit (12 Mos) | $35.6M |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 5 days ago
Novo Nordisk (CPSE:NOVO B) Reaches LX9851 Obesity Drug Milestone
Yahoo Finance • 5 days ago
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
Yahoo Finance • 22 days ago
Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ...
Yahoo Finance • 23 days ago
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |